RONALD A DEPINHO to Antineoplastic Agents
This is a "connection" page, showing publications RONALD A DEPINHO has written about Antineoplastic Agents.
Connection Strength
0.363
-
Cancer drug discovery faces the FACT. Sci Transl Med. 2011 Aug 10; 3(95):95ps34.
Score: 0.079
-
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science. 2007 Oct 12; 318(5848):287-90.
Score: 0.060
-
The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov. 2006 Sep; 5(9):741-54.
Score: 0.056
-
Telomere dysfunction alters the chemotherapeutic profile of transformed cells. Proc Natl Acad Sci U S A. 2001 Mar 13; 98(6):3381-6.
Score: 0.038
-
An enolase inhibitor for the targeted treatment of ENO1-deleted cancers. Nat Metab. 2020 12; 2(12):1413-1426.
Score: 0.038
-
Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma. Cancer Cell. 2019 06 10; 35(6):868-884.e6.
Score: 0.034
-
Passenger deletions generate therapeutic vulnerabilities in cancer. Nature. 2012 Aug 16; 488(7411):337-42.
Score: 0.021
-
Towards patient-based cancer therapeutics. Nat Biotechnol. 2010 Sep; 28(9):904-6.
Score: 0.018
-
Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res. 2006 Apr 15; 66(8):4368-77.
Score: 0.014
-
Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell. 2011 Sep 13; 20(3):289-99.
Score: 0.005